| Open | High | Low | Prev Close | 52 week High-Low | | 46.29 | 46.71 | 45.08 | 46.37 | 48.79 - 37.02 | | Volume | 90 Day Avg. Volume | Shares Outstanding | Market Cap | P/E | EPS | | 21,737.0 thou | 16,263.4 thou | 3,019.6 mil | 138.9 bil | 23.6 | 1.95 | | Indicated Annual Dividend | Divd. Yield | Beta | Ex. Divd. | Divd. Pay | Split Date | | 1.72 | 3.7% | 0.63 | 3/13/2013 | 4/5/2013 | 2/17/1999 |
Description Merck & Co Inc is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. Fundamentals | | MRK
Fundamentals | Industry
Fundamentals | S&P500
Fundamentals | Rating vs.
Industry | Rating vs.
S&P500 |
|---|
| Price/Earnings | 23.6 | 20.2 | 22.9 | - | - | | Price/Book Value | 2.6 | 5.5 | 4.4 | + | + | | Dividend Yield% | 3.7 | 2.1 | 2.1 | + | + | | 5yr EPS Growth Rate(%) | -12.8 | 4.0 | 9.4 | - | - | | Growth Consistency | 2.0 | 20.8 | 23.4 | - | - | | Return on Equity(%) | 14.9 | 20.3 | 29.5 | - | - | | Price Volatility | 1.2 | 4.5 | 1.5 | + | + |
Financial Highlights Latest Fiscal Year (Mar 2013)| Sales | $46.21 billion | | Book Value Per Shr | $17.57/shr | | Debt/Equity | 0.30 | | Profit Margin | 17.1% | | Earnings | $7.91 billion | Latest Dividend Data| Indicated Annual Dividend | $1.72/share | | Dividend Yield | 3.7% | | Dividend Payout | 87.00% | | Ex-Dividend Date | 3/13/2013 | | Dividend Pay Date | 4/5/2013 | Latest Data| EPS Latest 12mos | $1.95/shr | | Market Cap | $138.87 billion | | Shares | 3.02 billion | | Preferred Shares | - | | Split Date | 2/17/1999 | | Debt | $16.09 billion | General Stats| Price/Sales | 3.01 | | Exchange | NYSE | | Beta 1 Year | 0.63 | | % Held By Institutions | 72.30% | | Dow 30 Member |  | | S&P 500 Member | | History Quarterly History| | 03/13 | 12/12 | 09/12 | 06/12 | 03/12 |
|---|
| Sales(bil) | $10.67 | $11.74 | $11.49 | $12.31 | $11.73 | | Income(bil) | $1.62 | $6.30 | $0.00 | $0.00 | $0.00 | | EPS | 0.52 | 0.29 | 0.56 | 0.58 | 0.56 | | Dividends | 0.43 | 0.43 | 0.42 | 0.42 | 0.42 | | Shares OS(bil) | 3.02 | 3.03 | 3.04 | 3.04 | 3.04 | Yearly History| | 12/12 | 12/11 | 12/10 | 12/09 | 12/08 |
|---|
| Sales(bil) | $47.27 | $48.05 | $45.99 | $27.43 | $23.85 | | Dep'n(bil) | $6.98 | $7.43 | $7.38 | $2.58 | $1.63 | | EBIT(bil) | $9.88 | $8.98 | $3.36 | $4.02 | $6.09 | | Income(bil) | $6.30 | $0.00 | $0.00 | $0.00 | $7.81 | | Margin | 13.3% | 0.0% | 0.0% | 0.0% | 32.7% | | EPS | 2.00 | 2.02 | 0.28 | 5.65 | 3.64 | | Dividends | 1.69 | 1.56 | 1.52 | 1.52 | 1.52 | | Payout | 72.38 | 57.09 | 47.85 | 44.90 | 43.63 | | Price/Earnings | 20.50 | 18.70 | 128.70 | 6.50 | 8.40 | | Price/Sales | 2.62 | 2.39 | 2.42 | 4.14 | 2.69 | | Price/Book | 2.34 | 2.10 | 2.04 | 1.92 | 3.42 | Balance Sheet Yearly History| | 12/12 | 12/11 | 12/10 | 12/09 | 12/08 |
|---|
| Current Assets(bil) | $34.86 | $33.18 | $29.06 | $28.43 | $19.30 | | Current Liabs(bil) | $18.35 | $16.25 | $15.64 | $15.75 | $14.32 | | LT Debt(bil) | $16.25 | $15.53 | $15.48 | $16.07 | $3.94 | | Book Value/Share | $17.52 | $17.93 | $17.64 | $19.00 | $8.90 | | Share OS(bil) | 3.03 | 3.04 | 3.08 | 3.11 | 2.11 | | Return on Equity | 11.9% | 0.0% | 0.0% | 0.0% | 41.6% | | Return on Assets | 5.9% | 0.0% | 0.0% | 0.0% | 16.5% | | Debt/Equity | 0.31 | 0.28 | 0.28 | 0.27 | 0.21 | |
